Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

about

Impact of lenalidomide-based induction therapy on the mobilization of CD34(+) cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.

P2860

Q38691698-87FF3800-E82E-4A5B-AD42-9C055206930B

P2860

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

Item

http://www.wikidata.org/entity/Q48130246

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

@en

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

@nl

type

Item

label

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

@en

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

@nl

prefLabel

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

@en

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

@nl

P1476

Cost analysis of a randomized stem cell mobilization study in multiple myeloma

@en

P2093

Eeva-Riitta Savolainen

http://www.w3.org/2001/XMLSchema#string

Eija Mahlamäki

http://www.w3.org/2001/XMLSchema#string

Esa Jantunen

http://www.w3.org/2001/XMLSchema#string

Jouni Ahonen

http://www.w3.org/2001/XMLSchema#string

Kari Remes

http://www.w3.org/2001/XMLSchema#string

Marja Sankelo

http://www.w3.org/2001/XMLSchema#string

Marjaana Säily

http://www.w3.org/2001/XMLSchema#string

Mervi Putkonen

http://www.w3.org/2001/XMLSchema#string

Pekka Anttila

http://www.w3.org/2001/XMLSchema#string

Pentti Mäntymaa

http://www.w3.org/2001/XMLSchema#string

P2860

European perspective on multiple myeloma treatment strategies in 2014

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents.

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Current status of stem cell mobilization.

Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs.

P304

1653-1659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-016-2772-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ville Varmavuo

Raija Silvennoinen

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27485453

http://www.w3.org/2001/XMLSchema#string

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

about

P2860

P2860

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698